LY-3325656

N/A

Report date: 2023/10/23 09:47:14
NME

Base Information

Drug NameLY-3325656
Drug Alias NameLY-3325656
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProbable G-protein coupled receptor 142 agonists
TargetsProbable G-protein coupled receptor 142
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A